D3 BIO

D3 BIO is a global biotechnology company focused on the development of precision therapies for oncology and immunology. The company's current R&D programs are designed not only to address unmet clinical needs but also to serve as core "pillars" that empower subsequent drug development. Its pipeline currently includes multiple first-in-class and/or best-in-class therapeutic candidates globally.Through internal R&D and external licensing, D3 BIO strategically builds a pipeline with significant clinical value and synergistic effects, maximizing the enrichment and optimization of its product portfolio while developing more combination therapies. This continuous cycle of driving drug discovery and innovation lies at the core of D3 BIO’s mission. The company’s English name, D3Bio, reflects this philosophy: Development → facilitates Discovery, which in turn drives further Development.